Scholars Central

CommentaryPublished 15 Feb 2007

Why Not Clozapine?

Authors: Deanna L. Kelly, Julie Kreyenbuhl, Robert W. Buchanan, Anil K. Malhotra

Clinical Schizophrenia & Related Psychoses

Volume 1 · Issue 1 · Pages 92–95

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Clozapine is the only antipsychotic medication approved for treatment-resistant schizophrenia. The superiority of this second-line antipsychotic for reducing positive psychotic symptoms compared to other antipsychotics in treatment-resistant schizophrenia is well established. Clozapine is also effective for reducing suicide risk and physical aggression, reducing hospitalizations and overall treatment costs, improving quality of life and is associated with a longer treatment duration compared to most other antipsychotic agents. Despite these positive attributes, the prescription of clozapine in the U.S. is infrequent and disproportionately low relative to the estimated prevalence of treatment-resistant schizophrenia. In fact, use of clozapine in the U.S. accounts for approximately 5% of all antipsychotic prescriptions and is much less widely used than in other countries. Many possible explanations likely contribute to clozapine’s underuse in the U.S. including the potential for serious side effects. However, new advances in genetic testing that may help predict risk for agranulocytosis may soon make clozapine a more viable treatment option. Efforts to understand the apparent under prescribing of clozapine and to provide education and interventions to optimize its use in appropriate patients should be undertaken.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Clinical Schizophrenia & Related Psychoses.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Schizophrenia & Related Psychoses
  • SubjectMental Health and Psychology
  • BylineArticles whose byline prints “Deanna L. Kelly”
  • BylineArticles whose byline prints “Julie Kreyenbuhl”
  • BylineArticles whose byline prints “Robert W. Buchanan”
  • BylineArticles whose byline prints “Anil K. Malhotra”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels